Dr. Harousseau - VELCADE/Dexamethasone (Vel/D) Versus VAD as Induction Treatment Prior to Autologous Stem Cell Transplantion (ASCT) in Newly Diagnosed Multiple Myeloma (MM): Updated Results of the IFM 2005/01 Trial
Jean Luc Harousseau, MD Hematologie Clinique CHU Hotel Dieu Nantes, France Member, IMF Board of Scientific Advisors
back
print
related articles
Be the first to comment